SNCA and Parkinson disease: In the context of PD, inhibition of Stearoyl-CoA desaturase 1 (SCD1), which is a downstream target of SREBP1, seems sufficient to suppress α-Synuclein induced-toxicity in yeast and human neurons (15,52).